AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement

• Post author:GHIAA Admin
• Post published:September 14, 2022
• Post category:

Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement

CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

• Post author:GHIAA Admin
• Post published:May 23, 2022
• Post category:

Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

• Post author:GHIAA Admin
• Post published:May 23, 2022
• Post category:

Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement

• Post author:GHIAA Admin
• Post published:April 18, 2022
• Post category:

Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement

Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement

• Post author:GHIAA Admin
• Post published:March 3, 2022
• Post category:

Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement

CEPI – Valneva, Chikungunya Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:August 23, 2021
• Post category:

Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement